Method for identification of T-cell epitopes and use for preparing molecules with reeduced immunogenicity

Details for Australian Patent Application No. 2002256624 (hide)

Owner Merck Patent GmbH

Inventors Carr, Francis J.; Carter, Graham; Williams, Stephen; Jones, Tim; Hamilton, Anita

Agent Davies Collison Cave

Pub. Number AU-B-2002256624

PCT Pub. Number WO2002/069232

Priority 01107568.6 27.03.01 EP; 01105777.5 08.03.01 EP; 01107012.5 20.03.01 EP; 01113228.9 30.05.01 EP; 01126859.6 12.11.01 EP; 01106899.6 20.03.01 EP; 01103954.2 19.02.01 EP; 01106538.0 15.03.01 EP; 01106536.4 15.03.01 EP; 01124965.3 19.10.01 EP; 01110220.9 25.04.01 EP

Filing date 18 February 2002

Wipo publication date 12 September 2002

Acceptance publication date 6 December 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/11 (2006.01) Medicinal preparations containing peptides

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002256624

6 December 2007 Application Accepted

  Published as AU-B-2002256624

24 January 2008 Corrigenda

  Applications Accepted - Name Index Under the name Merck Patent GmbH, Application No. 2002256624, under INID (54), correct the invention title to read Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256625-METHOD AND SYSTEM FOR MULTIPLE HOSTS ANYCAST ROUTING

2002256623-CABLE CONNECTION APPARATUS